Paul McEwan
Paul McEwan
Scientific Advisor
Paul has 25+ years of experience in the life science tools space as both an entrepreneur and investor. He started his career developing technology for the Human Genome Project at the Whitehead Institute Center for Genome Research. Paul co-founded several LS tools companies including Agencourt Bioscience, Agencourt Personal Genomics, and Kapa Biosystems, which generated a combined exit value of $700M.
He has made 20+ investments in life science start-ups as an angel investor and is a board member at Watchmaker Genomics, SeqWell, Scribe Biosciences, DNA Script, and Oligo Factory.